Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study

The Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in death and cardiovascular disease (CVD) risk with a systolic blood pressure (SBP) goal of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2021-03, Vol.18 (3), p.e1003515-e1003515
Hauptverfasser:	Li, Chao, Chen, Kangyu, Cornelius, Victoria, Tomeny, Ewan, Wang, Yang, Yang, Xiaowei, Yuan, Xiaodan, Qin, Rui, Yu, Dahai, Wu, Zhenqiang, Wang, Duolao, Chen, Tao
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Age Antihypertensives Blood pressure Cardiovascular disease Cardiovascular diseases Care and treatment Complications and side effects Coronary artery disease Cost analysis Heart diseases Hypertension Medicine and Health Sciences Mortality Population Population studies Prescription drugs Prevention Purchasing power parity Regulation Risk factors Social Sciences Stroke
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in death and cardiovascular disease (CVD) risk with a systolic blood pressure (SBP) goal of
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.1003515